Laden…
5-amyl-2-[(1R,6R)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]resorcinol
CBD (Cannabidiol) is a non-psychoactive cannabinoid from the cannabis plant, primarily known for its anti-inflammatory, anxiolytic, and neuroprotective properties. It mainly acts by modulating the endocannabinoid system and influences various receptors, including CB1, CB2, 5-HT1A, and TRPV1. Due to its favorable safety profile, CBD is increasingly being studied in research and medicine. It does not cause intoxicating effects and has a low risk of side effects or dependence.
Class
Cannabinoide
Pharmacological context
Mechanism
CBD interacts with the endocannabinoid system, particularly with the...
Short read on known pharmacology
Interactions
No curated pairs visible
Curated visible combinations
Risk theme
Low Risk
Condensed from structured notes
Receptor Targets
Mechanism of Action
Designations
IUPAC: 5-amyl-2-[(1R,6R)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]resorcinol
Synapedia Evidence
CBD interacts with the endocannabinoid system, particularly with the CB1 and CB2 receptors. It modulates the effects of endocannabinoids and has potentially anti-inflammatory and anxiolytic properties.
Known Effects
Individual effects may vary significantly. These are pharmacologically documented effects.
Reported range 10–30 mg
Total duration 4–8 hours
Oral
| Tier | Dosage |
|---|---|
| Light | 5–10 mg |
| Reported | 10–30 mg |
| Strong | 30–100 mg |
Sublingual
| Tier | Dosage |
|---|---|
| Light | 2–5 mg |
| Reported | 5–15 mg |
| Strong | 15–50 mg |
Vaporisiert
| Tier | Dosage |
|---|---|
| Light | 1–3 mg |
| Reported | 3–10 mg |
| Strong | 10–20 mg |
Onset
30–90 minutes (oral), 15–30 minutes (sublingual), 5–10 minutes (vaporized)
Peak
1–3 hours (oral), 30–90 minutes (sublingual), 30 minutes (vaporized)
Total duration
4–8 hours
Avoid uncertain dosage claims and do not infer numbers when data is unclear.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks & Harm Reduction is partially translated. Some details are still being expanded.
Risks
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Interaction details from the knowledge layer are still being translated.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.